Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Hengtong Pharmaceutical Development is a specialized pharmaceutical research and development enterprise based in Nanjing, China. Established in 2002, the company focuses on the development of high-end generic drugs, innovative small molecules, and the consistency evaluation of existing medications. They offer a full suite of services ranging from chemical synthesis and formulation research to clinical trial coordination and regulatory filing. Hengtong has established a strong reputation for its technical expertise in complex formulations and has successfully partnered with numerous large-scale pharmaceutical manufacturers. Their portfolio spans multiple therapeutic areas, including cardiovascular health, oncology, and immunology. The company's mission is to enhance drug accessibility and quality through rigorous scientific innovation and efficient R&D processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Hengtong Pharmaceutical Development.